963 related articles for article (PubMed ID: 26598546)
1. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
[TBL] [Abstract][Full Text] [Related]
2. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity.
Lazzeri D; Agostini T; Bocci G; Giannotti G; Fanelli G; Naccarato AG; Danesi R; Tuccori M; Pantaloni M; D'Aniello C
Clin Breast Cancer; 2011 Oct; 11(5):283-96. PubMed ID: 21729665
[TBL] [Abstract][Full Text] [Related]
3. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
Tabanelli V; Corsini C; Fiori S; Agostinelli C; Calleri A; Orecchioni S; Melle F; Motta G; Rotili A; Di Napoli A; Pileri SA
Hum Pathol; 2019 Aug; 90():60-69. PubMed ID: 31125630
[TBL] [Abstract][Full Text] [Related]
4. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
[TBL] [Abstract][Full Text] [Related]
5. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity.
Xu J; Wei S
Arch Pathol Lab Med; 2014 Jun; 138(6):842-6. PubMed ID: 24878027
[TBL] [Abstract][Full Text] [Related]
6. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
[TBL] [Abstract][Full Text] [Related]
7. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
[TBL] [Abstract][Full Text] [Related]
8. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
[TBL] [Abstract][Full Text] [Related]
9. Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment.
Kaartinen I; Sunela K; Alanko J; Hukkinen K; Karjalainen-Lindsberg ML; Svarvar C
Eur J Surg Oncol; 2017 Aug; 43(8):1385-1392. PubMed ID: 28625797
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A; Soma L
Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
[TBL] [Abstract][Full Text] [Related]
11. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature.
Miranda RN; Lin L; Talwalkar SS; Manning JT; Medeiros LJ
Arch Pathol Lab Med; 2009 Sep; 133(9):1383-90. PubMed ID: 19722744
[TBL] [Abstract][Full Text] [Related]
13. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
Irshaid L; Xu ML
Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
[TBL] [Abstract][Full Text] [Related]
14. High intratumoural galectin-1 expression predicts adverse outcome in ALK
Holst JM; Ludvigsen M; Hamilton-Dutoit SJ; Bendix K; Plesner TL; Nørgaard P; Møller MB; Steiniche T; Rabinovich GA; d'Amore F; Pedersen MB
Hematol Oncol; 2020 Feb; 38(1):59-66. PubMed ID: 31834627
[TBL] [Abstract][Full Text] [Related]
15. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.
Wu D; Allen CT; Fromm JR
Cytometry B Clin Cytom; 2015 Jan; 88(1):58-63. PubMed ID: 25044944
[TBL] [Abstract][Full Text] [Related]
17. Cytological Diagnosis of Bilateral Breast Implant-Associated Lymphoma of the ALK-Negative Anaplastic Large-Cell Type. Clinical Implications of Peri-Implant Breast Seroma Cytological Reporting.
Granados R; Lumbreras EM; Delgado M; Aramburu JA; Tardío JC
Diagn Cytopathol; 2016 Jul; 44(7):623-7. PubMed ID: 27079579
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic large-cell lymphoma in women with breast implants.
de Jong D; Vasmel WL; de Boer JP; Verhave G; Barbé E; Casparie MK; van Leeuwen FE
JAMA; 2008 Nov; 300(17):2030-5. PubMed ID: 18984890
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) of breast in a patient without a breast implant.
Sathyanarayanan V; Lokesh KN; Lakshmaiah KC; Govind Babu K; Lokanatha D; Suresh Babu MC; Rao CR; Chennagiri P
Ann Saudi Med; 2014; 34(6):551-4. PubMed ID: 25971833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
